Mesenchymal stem cells in bone tissue engineering: osteogenic activity, immunogenicity, proangiogensis and osteogenesis

doi:10.3969/j.issn.2095-4344.2016.46.016

Abstract

Abstract:

BACKGROUND: It is still a challenge to repair bone defects caused by trauma, infection, tumor and congenital diseases. Bone tissue engineering is a promising method for bone defect repair showing important guiding significance in the clinic.
OBJECTIVE: To review the progress of proliferation, osteogenic activity, immunogenicity, proangiogensis and in vivo osteogenic effect of mesenchymal stem cells in bone tissue engineering.
METHODS: The first author retrieved Wanfang and PubMed datebase for literatures published from 2008 to 2016, using the keywords of “mesenchymal stem cell, tissue engineering, osteogenesis, immune property, angiogenesis” in Chinese and English, respectively. Articles regarding mesenchymal stem cells, tissue engineering, osteogenesis, immune property and angiogenesis were included, and repetitive and dated studies were excluded. Totally 1 772 articles were retrieved initially, and in accordance with inclusion and exclusion criteria, 41 eligible articles were included for review analysis.
RESULTS AND CONCLUSION: Bone marrow mesenchymal stem cells and adipose-derived mesenchymal stem cells are extensively applied in bone tissue engineering. Studies have shown that the osteogenic activity of bone marrow mesenchymal stem cells is higher than that of adipose-derived mesenchymal stem cells, but its immune regulation effect is weaker than that of adipose-derived mesenchymal stem cells. Mesenchymal stem cells hold remarkable immune regulation (immunosuppression and immune enhancement) and tissue repair capacity, which can eliminate inflammatory reactions at injured sites, promoting tissue repair. Adipose-derived mesenchymal stem cells cultured under hypoxia environment can secret more angiogenic cytokines generating more vascular structures. Furthermore, increasing proof have confirmed that porous nano-polylactic acid combined with nano-carbon biological material can significantly promote the proliferation and osteogenesis of bone marrow mesenchymal stem cells. Taking its tumorigenesis into consideration, mesenchymal stem cells should be prudently used in the clinic.

中国组织工程研究杂志出版内容重点：组织构建；骨细胞；软骨细胞；细胞培养；成纤维细胞；血管内皮细胞；骨质疏松；组织工程

Key words: Mesenchymal Stem Cells, Bone and Bones, Immunity, Tissue Engineering

CLC Number:

R318

Chen Zhen-dong1, Xu Fang-tian2, Gao Hui2. Mesenchymal stem cells in bone tissue engineering: osteogenic activity, immunogenicity, proangiogensis and osteogenesis[J]. Chinese Journal of Tissue Engineering Research, 2016, 20(46): 6956-6956.

Figures/Tables 1

References

[1] Yousefi AM, James PF, Akbarzadeh R,et al. Prospect of Stem Cells in Bone Tissue Engineering: A Review. Stem Cells Int.2016;2016:6180487.
[2] Rao RR, Stegemann JP. Cell-based approaches to the engineering of vascularized bone tissue.Cytotherapy. 2013;15(11):1309-1322.
[3] Pina S,Oliveira JM,Reis RL.Natural-based nanocomposites for bone tissue engineering and regenerativemedicine: a review. Adv Mater. 2015; 27(7): 1143-1169.
[4] Shi Y,Hu G,Su J,et al.Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res.2010;20(5):510-518.
[5] Burlacu A,Grigorescu G, Rosca AM,et al.Factors secreted by mesenchymal stem cells and endothelial progenitor cells have complementary effects on angiogenesis in vitro. Stem Cells Dev.2013;22(4):643-653.
[6] 曾晶晶,周诺,黄旋平等.犬骨髓间质干细胞体外培养和鉴定[J].实用医学杂志,2013,29(16):2649-2651.
[7] 吴尉,梁芳,宋小琴,等.人脂肪干细胞的提取和鉴定[J].中国组织工程研究,2015,19(28):4498-4502.
[8] 卢遥,王静成,顾加祥，等.兔胎盘来源间充质干细胞修复兔桡骨骨缺损的实验研究[J].中华创伤骨科杂志, 2011, 13(11):1060-1065.
[9] 杜晶春,朱蕊,徐霞,等.人羊水来源间质干细胞的鉴定及其免疫调节功能和相关机制研究[J].实用医学杂志, 2013, 29(4):529-532.
[10] Vishnubalaji R, Al-Nbaheen M, Kadalmani B, et al.Comparative investigation of the differentiation capability of bone-marrow- andadipose-derived mesenchymal stem cells by qualitative and quantitative analysis.Cell Tissue Res. 2012;347(2):419-427.
[11] Zhang W, Zhang X, Wang S,et al. Comparison of the use of adipose tissue-derived and bone marrow-derived stemcells for rapid bone regeneration. J Dent Res. 2013;92(12):1136-1141.
[12] Wen Y,Jiang B,Cui J,et al.Superior osteogenic capacity of different mesenchymal stem cells for bone tissue engineering.Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(5):e324-332.
[13] Hass R,Kasper C,BöhmS,et al.Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal.2011;9:12.
[14] Li X,Bai J,JiX,et al.Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation. Int J Mol Med.2014;34(3):695-704.
[15] De Francesco F, Ricci G, D'AndreaF,et al. Human Adipose Stem Cells: From Bench to Bedside. Tissue Eng Part B Rev.2015;21(6):572-584.
[16] Ren G, Zhang L, Zhao X,et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action ofchemokines and nitric oxide.Cell Stem Cell. 2008;2(2):141-150.
[17] Ren G, Su J, Zhang L,et al. Species variation in the mechanisms of mesenchymal stem cell- mediatedimmunosuppression. Stem Cells. 2009; 27(8):1954-1962.
[18] Li W,RenG,Huang Y, et al.Mesenchymal stem cells:a double-edged sword in regulating immune response. Cell Death Differ 2012;19:1505-1513
[19] Montespan F,Deschaseaux F, Sensébé L,et al.Osteodifferentiated mesenchymal stem cells from bone marrow and adipose tissueexpress HLA-G and display immunomodulatory properties in HLA-mismatched settings:implications in bone repair therapy.JImmunol Res. 2014;2014:230346.
[20] Melief SM, Zwaginga JJ, FibbeWE,et al.Adipose tissue-derived multipotent stromal cells have a higher immunomodulatorycapacity than their bone marrow-derived counterparts. Stem Cells Transl Med. 2013;2(6):455-463.
[21] Ribeiro A, Laranjeira P, Mendes S,et al.Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrowexhibit different capability to suppress peripheral blood B, natural killer and Tcells.Stem Cell Res Ther.2013;4(5):125.
[22] Najar M, Raicevic G, BoufkerHI,et al. Mesenchymal stromal cells use PGE2 to modulate activation and proliferation oflymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly andbone marrow sources.Cell Immunol. 2010;264(2):171-179.
[23] Boukhechba F,Balaguer T,Bouvet-Gerbettaz S,et al.Fate of bone marrow stromal cells in a syngenic model of bone formation.TissueEng Part A 2011;17:2267-2278.
[24] Mendez JJ, Ghaedi M, Sivarapatna A,et al. Mesenchymal stromal cells form vascular tubes when placed in fibrin sealant andaccelerate wound healing in vivo. Biomaterials.2015;40:61-71.
[25] Correia C,Grayson WL,Park M,et al.In vitro model of vascularized bone:synergizing vascular development and osteogenesis.PLoS One.2011;6(12),e28352.
[26] Verseijden F, Posthumus-van Sluijs SJ, Pavljasevic P,et al. Adult human bone marrow- and adipose tissue-derived stromal cells support theformation of prevascular-like structures from endothelial cells in vitro. Tissue Eng Part A. 2010;16(1):101-114.
[27] Edwards SS, Zavala G, Prieto CP,et al. Functional analysis reveals angiogenic potential of human mesenchymal stem cells from Wharton's jelly in dermal regeneration.Angiogenesis. 2014;17(4):851-866.
[28] Rubina K,Kalinina N,Efimenko A,et al.Adipose stromal cells stimulate angiogenesis via promoting progenitor celldifferentiation, secretion of angiogenic factors, and enhancing vesselmaturation. Tissue Eng Part A. 2009; 15(8):2039-2050.
[29] Watt SM, Gullo F, van der Garde M,et al.The angiogenic properties of mesenchymal stem/stromal cells and their therapeuticpotential. Br Med Bull. 2013; 108:25-53.
[30] Kim KI, Park S, Im GI.Osteogenic differentiation and angiogenesis with cocultured adipose-derivedstromal cells and bone marrow stromal cells. Biomaterials. 2014;35(17):4792-4804.
[31] Freiman A, Shandalov Y, Rozenfeld D,et al. Adipose-derived endothelial and mesenchymal stem cells enhance vascular network formation on three-dimensional constructs in vitro.Stem Cell Res Ther.2016;7(1):5.
[32] Niemeyer P, Fechner K, Milz S,et al.Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma. Biomaterials. 2010;31(13):3572-3579.
[33] Hung BP, Hutton DL, Kozielski KL,et al. Platelet-Derived Growth Factor BB Enhances Osteogenesis of Adipose-Derived But Not Bone Marrow-Derived Mesenchymal Stromal/Stem Cells. Stem Cells. 2015;33(9):2773-2784.
[34] Yang Y, Wu J, Jin G,et al. Research of osteoblastic induced rat bone marrow mesenchymal stem cells cultured on β-TCP/PLLA porous scaffold. Int J ClinExp Med. 2015;8(3):3202-3209.
[35] Duan S, Yang X, Mei F,et al. Enhanced osteogenic differentiation of mesenchymal stem cells on poly(L-lactide) nanofibrous scaffolds containing carbon nanomaterials. J Biomed Mater Res A. 2015;103(4):1424-1435.
[36] 王立勋,吕飞舟,马晓生,等.慢病毒介导骨形成蛋白-2基因转染骨髓间质干细胞修复大鼠颅骨骨缺损[J].中华实验外科杂志,2008,25(6):705-706.
[37] 王庆,陈光兴,郭林,等.骨形态发生蛋白-2和7联合基因修饰构建组织工程骨的实验研究[J].中华创伤骨科杂志, 2013,15(11):984-989.
[38] Pak J, Chang JJ, Lee JH,et al. Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints. BMC MusculoskeletDisord. 2013;14:337.
[39] Pak J, Lee JH, Lee SH. Regenerative repair of damaged meniscus with autologous adipose tissue-derived stem cells. Biomed Res Int.2014;2014:436029.
[40] Ra JC, Shin IS, Kim SH,et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans.Stem Cells Dev. 2011;20(8):1297-1308.
[41] Rhee KJ, Lee JI, Eom YW. Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression.Int J Mol Sci.2015;16(12):30015-30033